Independent Investment Research

Independent Investment Research, “IIR”, is an independent investment research house based in Australia and the United States. IIR specialises in independent research in small/ micro cap equities across sectors and managed investment ratings both...


No areas of expertise

Tinybeans Group Limited (ASX: TNY) - Social Media Platform - Baby/ Child Sector - Strong US Presence

Independent Investment Research

TNY is a mobile and web-based social media platform that allows parents to record and share their children’s moments and milestones with family and friends. Unlike more general social media platforms, TNY is solely for this purpose, providing a platform without other distractions or privacy concerns that may otherwise arise... Show More


Beston Global Food Company Ltd - Selling Food to the Growing Asian Population

Independent Investment Research

We have initiated coverage on Beston Global Food Company Limited (ASX: BFC) - BFC is a branded food company that aims to provide high quality, safe, clean, differentiated food and beverage products to consumers with ingredient integrity and a secure supply chain to provide consumers with an authentic, genuine and... Show More


Recent Acquisition Provides Direct Access To Canadian Medical Cannabis Market

Independent Investment Research

Creso Pharma Limited (ASX:CPH) - In July 2017, the company announced the acquisition of Mernova Medicinal Inc. (Mernova), a privately held company based in Nova Scotia, Canada. CPH will acquire 100% of Mernova for a total of CAD$10.1m. The acquisition provides direct access to the Canadian market, one of the... Show More


K2 Australian Small Cap Fund (Hedge Fund) (ASX: KSM) - IIR Rating RecommendationReview

Independent Investment Research

K2 Australian Small Cap Fund (Hedge Fund), (ASX code: KSM), is an Active Exchange Traded Fund (Active ETF). KSM was listed in December 2015. KSM provides exposure to an actively managed, index unaware, long/short portfolio of ASX and NZ small cap stocks with an absolute return objective. The Fund commenced... Show More


Race Oncology Limited: Leukaemia Treatment

Independent Investment Research

RAC intends to make Bisantrene available for use in Europe and South Korea under a Named Patient Program (NPP) over the next two years. The company is also seeking to gain approval by the FDA for its drug via the 505(b)(2) route. Show More


Join the conversation

Magellan Global Trust receives Recommended Plus rating

Independent Investment Research

Magellan’s Global Trust (MGG) will shake things up when it hits the ASX next month with a range of innovative features not previously seen in the Australian listed investments landscape. It will be based on a high conviction, relatively concentrated global equities and benchmark agnostic mandate with a portfolio of... Show More

ASX:MFG Sponsored Content ASX:MGE ASX:MGG Magellan Global Trust

Novonix Limited - Lithium Ion Battery Testing Equipment - Supplier to Tesla & Like Brands

Independent Investment Research

Novonix Limited (ASX: NVX), previously GraphiteCorp Limited (ASX: GRA), has transformed from a developer of a flake graphite deposit into a supplier of advanced battery materials, equipment and services to the global Lithium Ion Battery (LIB) market - NOVONIX designs, manufactures and supplies high precision Lithium Ion Battery (LIB) testing... Show More


Creso Pharma Limited - First Company to Import Medicinal Cannabis Product into Australia

Independent Investment Research

Through its partnership with Health House International Pty Ltd (Health House), Creso was the first company to successfully import medicinal cannabis products into Australia under the new Federal Government legislation. The company continued to expand its partner network with the company announcing it has signed a Letter of Intent (LOI)... Show More


Noxopharm Ltd - Clinical Trial Program Commences - Will be testing NOX66 with Radiotherapy

Independent Investment Research

This note is an update to our initiation note. The company has commenced a comprehensive clinical trial program that will see the initiation of 7 clinical trials throughout 2017. The first clinical trial is underway which focuses on using NOX66 in conjunction with chemotherapy on patients with late-stage cancers. The... Show More


How to identify outstanding LICs

Independent Investment Research

Listed Investment Companies (LICs) have enjoyed somewhat of a renaissance ever since the Future of Financial Advice (FOFA) reforms levelled the playing field with unlisted trusts. In the last four years, 42 new LICs have been listed, bringing the total combined market capitalisation for all LICS to $31 billion at... Show More

Join the conversation

Proteomics International Laboratories Ltd (ASX: PIQ) - Early Detection of Diabetic Kidney Disease - Commercialisation of Diagnostic Kit

Independent Investment Research

PIQ is a biological research and drug discovery company working on the development of simple diagnostic tests for common diseases and the discovery of new therapeutic drugs to treat pain and infection. The breakthrough diagnostic test has the potential to provide the company with significant upside value if the partners... Show More


Positioned for the expanding cannabis market

Independent Investment Research

Creso Pharma Limited will develop, register and commercialise food grade and medicinal grade cannabis, initially supplying food supplements for animals, entering the human food supplement market in the short term, and later supplying medicinal cannabis based products for chronically ill patients. Governments are progressively legalising the use of medicinal cannabis... Show More


Codan outperforms across all units

Independent Investment Research

CDA outperformed across all its business units in 1H17, with the Minelab division delivering returns above expectations on improved sales of the GPZ 7000. The company has continued to deliver earnings growth since the significant decline in earnings experienced in FY14 after the unprecedented increase in FY13 on the back... Show More


Easton Investments Limited (ASX: EAS) - Positive Momentum Continues in Core Business

Independent Investment Research

EAS is a diversified financial services company with three operating divisions: (1) Distribution Show More


IIR Research Rating - Forager Australian Shares Fund (ASX: FOR) - Initiation of Coverage

Independent Investment Research

The Forager Australian Shares Fund was launched in 2009 and is managed by Forager Funds Management Pty Ltd. The Fund is based on a long-only, high conviction Australian equities mandate and is managed by a small, but capable and proven investment team. The portfolio is overwhelmingly comprised of small... Show More


IIR LIC Research Rating - Perpetual Equity Investment Company Limited (ASX: PIC)

Independent Investment Research

We have just initiated coverage on PIC. The LIC provides exposure to an actively managed concentrated portfolio primarily of ASX-listed stocks. Interestingly, It can invest up to 25% of the portfolio in internationally listed stocks, providing the Investment Manager the ability to source value in other markets if it cannot... Show More


Hunter Hall Global Value Ltd (ASX: HHV) - Ratings Suspended - Under Review

Independent Investment Research

We have suspended our investment rating for HHV and placed the LIC under review Show More


Spring FG Limited (ASX: SFL) - Wealth Management - Small Cap Company Poised for Growth

Independent Investment Research

SFL currently has a small market capitalisation. SFL has established a diverse range of products and services to meet the complete investment requirements of retail investors - Client information is centralised so that the company can review client financial objectives and ensure that the optimal solutions are provided.The company forecasts... Show More


Contango MicroCap Ltd - Fund Ratings Suspended - Under Review

Independent Investment Research

We have suspended our investment rating for CTN and placed the LIC under review following an announcement by the company about changes to its investment management arrangements. Show More


Kyckr: Focus on automating the “Know Your Customer” process

Independent Investment Research

KYK was recently listed providing investors with the opportunity to gain exposure to the global KYC market. It has Bank of Ireland as a client and now looking sign on similar clients globally. KYK is a commercially proven technology company that supplies services, predominantly to banks, to manage their Know... Show More


No comments.